CAR-T cell therapy involves modifying a patient’s T cells to recognize and attack cancer cells more effectively. This personalized treatment approach has transformed outcomes in leukemia and lymphoma, offering durable responses and expanding the future of advanced cellular immunotherapies worldwide. https://www.xelleratherapeutics.com/services/custom-manufacturing-services/